BARDA Biomedical Advanced Research and Development Authority EZ BAA for COVID-19 Medical Countermeasures
At this time BARDA EZ BAA is accepting responses related to SARS-CoV-2 programs in the following areas:
4.3: COVID-19 Vaccines, and
4.4: Advanced Manufacturing Technologies.
BARDA partners with companies and teams offering solutions to a broad range of national health security threats. DRIVe partnering approaches vary depending on the project. DRIVe has two main solicitations, our EZ BAA for awards under $749K and our BAA Special Instructions for more involved projects.